New Leaf Venture Partners, L.L.C. Portfolio Holdings

New Leaf Venture Partners, L.L.C.

  • $74.2 Million
  • Q4 2024

New Leaf Venture Partners, L.L.C. has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $74.2 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arvinas, Inc. with a value of $30.4M, Edgewise Therapeutics, Inc. with a value of $27.5M, Crinetics Pharmaceuticals, Inc. with a value of $7.21M, Rallybio Corp with a value of $3.17M, and Cogent Biosciences, Inc. with a value of $1.96M.

Examining the 13F form we can see an decrease of $22.7M in the current position value, from $96.9M to 74.2M.

New Leaf Venture Partners, L.L.C. is based out at New York, NY

Below you can find more details about New Leaf Venture Partners, L.L.C. portfolio as well as his latest detailed transactions.

Portfolio value $74.2 Million
Healthcare: $74.2 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$138M
$641,000 0.86% of portfolio
339,569
Q2 2020 Reduced 46.91%

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $74.2 Million
  • Prior Value $96.9 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email